Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function

NCT03874117 is registered in ClinicalTrials.gov with Palo Alto Veterans Institute for Research as lead sponsor.

NCT NCT03874117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03874117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
Lead sponsor
Palo Alto Veterans Institute for Research
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2018
Completion date
May 31, 2025
Enrollment
58 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, kidney failure, chronic